Ebola virus: from discovery to vaccine

@article{Feldmann2003EbolaVF,
  title={Ebola virus: from discovery to vaccine},
  author={Heinz Feldmann and Steven J M Jones and Hans Dieter Klenk and Hans Schnittler},
  journal={Nature Reviews Immunology},
  year={2003},
  volume={3},
  pages={677-685}
}
Ebola virus, being highly pathogenic for humans and non-human primates and the subject of former weapons programmes, is now one of the most feared pathogens worldwide. In addition, the lack of pre- and post-exposure interventions makes the development of rapid diagnostics, new antiviral agents and protective vaccines a priority for many nations. Further insight into the ecology, immunology and pathogenesis of Ebola virus will promote the delivery of these urgently required tools. 
“An Outbreak Is Needed For Ebola Virus Treatment” A Review
Ebola virus causes acute hemorrhagic fever in humans and nonhuman primates. Ebola virus constitutes an important local public health threat in Africa, with worldwide effect through importedExpand
Ebola and Marburg Virus: A Brief Review
TLDR
The frequency, the rapid spread of epidemics, the mobilization of human, health and socioeconomic resources, the implementation of security measures, an effective management, and especially an effective vaccine against these viruses and their variants militate in favor of the preparation and the response. Expand
Ebola virus disease: a highly fatal infectious disease reemerging in West Africa
TLDR
Lack of effective antivirals, vaccines and public health infrastructures in parts of Africa make it difficult to health workers to contain the outbreak of Ebolavirus. Expand
A single shot against Ebola and Marburg virus
New vaccines protect monkeys from Ebola and Marburg virus infections after a single shot. The live vaccines are built using a virus platform that should allow widespread protection in people, if theExpand
Ebola virus ecology: a continuing mystery.
TLDR
Identification of the viral reservoir(s) of these zoonotic pathogens and the routes of primary transmission to human and nonhuman primates remains a mystery. Expand
Progress towards the treatment of Ebola haemorrhagic fever
TLDR
The authors discuss the most promising therapeutic approaches for Ebola haemorrhagic fever as judged by their efficacy in animal models and encourages discussions on how to move some of the experimental approaches towards clinical application. Expand
Ebola virus: unravelling pathogenesis to combat a deadly disease.
TLDR
The current knowledge on EBOV pathogenesis is summarized focusing on the impairment of the immune response and vascular dysfunction and on recent progress in the development of vaccines and potential therapeutics. Expand
Update on Ebola Virus and Its Potential as a Bioterrorism Agent
TLDR
The virus causes Ebola hemorrhagic fever, which is associated with a macular rash, disseminated intravascular coagulopathy, and multiorgan failure, and there is a concern that EBOV might be used as a bioterrorism agent that could be disseminated via the aerosol route. Expand
Ebola Virus Disease: A Biological and Epidemiological Perspective of a Virulent Virus
TLDR
This review aims at discussing the biology, epidemiology, risk factors as well as the pathogenesis of the disease in the hope demystifying the disease. Expand
The ecology of Ebola virus.
TLDR
There is an urgent need to better understand the ecology of Ebola virus in nature with the increasing frequency of human filovirus outbreaks and the tremendous impact of infection on the already threatened great ape populations. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 98 REFERENCES
Vaccine research efforts for filoviruses.
  • M. K. Hart
  • Biology, Medicine
  • International journal for parasitology
  • 2003
TLDR
The vaccine approaches discussed include DNA-based vaccines, and subunit vaccines vectored by adenovirus, alphavirus replicons, and vaccinia virus that identify the immune mechanisms of protection for Ebola and Marburg. Expand
[Attempts to develop a vaccine against Ebola fever].
TLDR
Antiviral immunity induced in guinea pigs by injection of inactivated viral agents did not protect them from infection, whereas injections of a nonlethal strain of the virus in ascending doses led to the formation of immunity preventing the development of disease upon inoculation with a lethal strain in high doses. Expand
Antibody-Dependent Enhancement of Ebola Virus Infection
TLDR
It is shown that Ebola Zaire virus infection in humans induces antibodies that enhance viral infectivity, and this enhancement was mediated by antibodies to the viral glycoprotein and by complement component C1q. Expand
Development of a preventive vaccine for Ebola virus infection in primates
TLDR
A combination of DNA immunization and boosting with adenoviral vectors that encode viral proteins generated cellular and humoral immunity in cynomolgus macaques demonstrates that it is possible to develop a preventive vaccine against Ebola virus infection in primates. Expand
Immunization for Ebola virus infection
TLDR
It is reported here that protection against the lethal effects of Ebola virus can be achieved in an animal model by immunizing with plasmids encoding viral proteins and developed through genetic vaccination. Expand
Preliminary report: isolation of Ebola virus from monkeys imported to USA
TLDR
This incident, the first in which a filovirus has been isolated from non-human primates without deliberate infection, raises the possibility that cynomolgus monkeys could be a reservoir of Ebola virus infection. Expand
Isolation and partial characterisation of a new strain of Ebola virus
TLDR
A new strain of Ebola virus is isolated from a non-fatal human case infected during the autopsy of a wild chimpanzee in the Côte-d'Ivoire, the first time that a human infection has been connected to naturally-infected monkeys in Africa. Expand
Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody
TLDR
Interestingly, some antibody-treated animals survived despite developing high-level viremia, suggesting that the mechanism of protection by KZ52 may extend beyond reduction of vireia by virus neutralization. Expand
Epitopes involved in antibody-mediated protection from Ebola virus.
TLDR
Several protective mAbs directed toward five unique epitopes on Ebola glycoprotein are identified, one of the epitopes is conserved among all Ebola viruses that are known to be pathogenic for humans. Expand
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
TLDR
The disease observed in primates differed from that in rodents, suggesting that rodent models of EBOV may not predict the efficacy of candidate vaccines in primates and that protection of primates may require different mechanisms. Expand
...
1
2
3
4
5
...